Cross Atlantic Partners

As of May 2009 CAP has achieved an aggregate 40% compound internal rate of return (IRR) and a 2.1X cash-on-cash return on completed investments.

Led the investment in September 1999 at a $22 million pre-money valuation.  Acquired by North American Scientific (NASI) in May 2004.   More details...

Impath, Inc., New York, NY

SunPharm Corp., Jacksonville, FL

NOMOS Corp., Cranberry Township, PA

Gene Logic, Inc., Gaithersburg, MD

ILEX Oncology, Inc., San Antonio, TX

Selected Completed investments

Led the investment in February 1995 at a $10 million pre-money valuation.  Fully exited in August 2000 at a $1.1 billion valuation.  More details...

Led the investment in April 1996 at a $4 million pre-money valuation.  Final exit in June 2000 at a $1.1 billion valuation.  More details...

Led the investment in April 1997 at a $17 million pre-money valuation.  Final exit in September 2001 at a $173 million valuation.  More details...

Led the investment in September 1995 at a $17 million pre-money valuation.  Fully exited in March 2000 at a $1.2 billion valuation.  More details...

Led the investment in February 2001 at a $330 million pre-money valuation.  So far, achieved a 2.6X cash-on-cash return on partial distributions of $20.0 million to date.   More details...

Martek Biosciences Corp., Columbia, MD

Led the investment in March 2004 at a $17.5 million pre-money valuation.  Acquired by YM BioSciences, Inc. in May 2006.   More details...

Eximias Pharmaceutical Corp., Berwyn, PA

Led the investment in May 1998 at a $14 million pre-money valuation.  Acquired by Centene Corporation in July 2005 at a valuation of nearly 1.6X our investment.   More details...

Airlogix Corporation, Dallas, TX

Led the investment in July 2001 at a $7.0 million pre-money valuation.  Acquired by Cerner Corporation in July 2006 at a valuation of more than 2X our investment.   More details...

Galt Associates, Inc., Sterling, VA

Invested in June 2002 at a $37 million pre-money valuation.  Acquired by US Surgical, a division of Tyco, in September 2006 at a $245 million valuation.   More details...

Confluent Surgical, Waltham, MA

Led the investment in March 2005 and exited above cost in March 2009.  To date, achieved a 1.1X cash-on-cash return on our investment.   More details...

Nutrition 21 Inc., Purchase, NY